Alkermes plc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Alkermes plc. (ALKS) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$65.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-07-28
- Alkermes plc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $501.00K, a 99.42% decline year-over-year.
- Alkermes plc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$66.48M, a 395.94% decline year-over-year.
- Alkermes plc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $49.34M, a 66.32% decline year-over-year.
- Alkermes plc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was $82.76M, a 10.41% decline year-over-year.
- Alkermes plc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was $241.66M, a 34.16% decline from fiscal 2024.
- Alkermes plc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was $367.07M, a 3.18% increase from fiscal 2023.
- Alkermes plc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was $355.76M.
- Alkermes plc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$158.27M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $501.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | -$65.98M 10-Q · filed 2026-07-28 | -$16.64M derived: sum of 3 quarters · filed 2026-07-28 | $66.12M derived: sum of 4 quarters · filed 2026-07-28 |
| 2026-03-31 | -$66.48M 10-Q · filed 2026-05-05 | -$17.14M derived: sum of 2 quarters · filed 2026-05-05 | $65.62M derived: sum of 3 quarters · filed 2026-05-05 | $152.72M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-12-31 | $49.34M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $132.10M derived: sum of 2 quarters · filed 2026-02-25 | $219.20M derived: sum of 3 quarters · filed 2026-07-28 | $241.66M 10-K · filed 2026-02-25 |
| 2025-09-30 | $82.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $169.86M derived: sum of 2 quarters · filed 2026-07-28 | $192.32M 10-Q · filed 2025-10-28 | $338.83M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-06-30 | $87.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $109.56M 10-Q · filed 2026-07-28 | $256.06M derived: sum of 3 quarters · filed 2026-07-28 | $348.45M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $22.46M 10-Q · filed 2026-05-05 | $168.97M derived: sum of 2 quarters · filed 2026-05-05 | $261.35M derived: sum of 3 quarters · filed 2026-05-05 | $352.71M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $146.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $238.88M derived: sum of 2 quarters · filed 2026-02-25 | $330.24M derived: sum of 3 quarters · filed 2026-02-25 | $367.07M 10-K · filed 2026-02-25 |
| 2024-09-30 | $92.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $183.74M derived: sum of 2 quarters · filed 2025-10-28 | $220.57M 10-Q · filed 2025-10-28 | $333.35M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $91.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $128.19M 10-Q · filed 2025-07-29 | $240.97M derived: sum of 3 quarters · filed 2026-02-25 | $288.72M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $36.83M 10-Q · filed 2025-05-01 | $149.61M derived: sum of 2 quarters · filed 2026-02-25 | $197.37M derived: sum of 3 quarters · filed 2026-02-25 | $434.43M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $112.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $160.54M derived: sum of 2 quarters · filed 2026-02-25 | $397.60M derived: sum of 3 quarters · filed 2026-02-25 | $355.76M 10-K · filed 2026-02-25 |
| 2023-09-30 | $47.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $284.82M derived: sum of 2 quarters · filed 2024-10-24 | $242.98M 10-Q · filed 2024-10-24 | $214.72M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $237.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $195.22M 10-Q · filed 2024-07-24 | $166.97M derived: sum of 3 quarters · filed 2025-02-12 | $102.99M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -$41.84M 10-Q · filed 2024-05-01 | -$70.10M derived: sum of 2 quarters · filed 2025-02-12 | -$134.07M derived: sum of 3 quarters · filed 2025-02-12 | -$164.21M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | -$28.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$92.23M derived: sum of 2 quarters · filed 2025-02-12 | -$122.36M derived: sum of 3 quarters · filed 2025-02-12 | -$158.27M 10-K · filed 2025-02-12 |
| 2022-09-30 | -$63.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | -$94.11M derived: sum of 2 quarters · filed 2023-10-25 | -$130.01M 10-Q · filed 2023-10-25 | -$129.14M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$30.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | -$66.04M 10-Q · filed 2023-07-26 | -$65.17M derived: sum of 3 quarters · filed 2024-02-21 | -$94.15M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$35.90M 10-Q · filed 2023-04-26 | -$35.03M derived: sum of 2 quarters · filed 2024-02-21 | -$64.02M derived: sum of 3 quarters · filed 2024-02-21 | -$61.65M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$28.11M derived: sum of 2 quarters · filed 2024-02-21 | -$25.75M derived: sum of 3 quarters · filed 2024-02-21 | -$48.17M 10-K · filed 2024-02-21 |
| 2021-09-30 | -$28.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$26.62M derived: sum of 2 quarters · filed 2022-11-02 | -$49.04M 10-Q · filed 2022-11-02 | -$91.68M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | -$20.05M 10-Q · filed 2022-07-27 | -$62.70M derived: sum of 3 quarters · filed 2023-02-16 | -$62.83M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$22.42M 10-Q · filed 2022-04-27 | -$65.06M derived: sum of 2 quarters · filed 2023-02-16 | -$65.19M derived: sum of 3 quarters · filed 2023-02-16 | -$94.63M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -$42.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$42.78M derived: sum of 2 quarters · filed 2023-02-16 | -$72.21M derived: sum of 3 quarters · filed 2023-02-16 | -$110.86M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | -$29.57M derived: sum of 2 quarters · filed 2021-10-27 | -$68.22M 10-Q · filed 2021-10-27 | -$73.57M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$29.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$68.08M 10-Q · filed 2021-07-28 | -$73.44M derived: sum of 3 quarters · filed 2022-02-16 | -$126.32M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$38.65M 10-Q · filed 2021-04-28 | -$44.01M derived: sum of 2 quarters · filed 2022-02-16 | -$96.89M derived: sum of 3 quarters · filed 2022-02-16 | -$138.88M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | -$5.35M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$58.23M derived: sum of 2 quarters · filed 2022-02-16 | -$100.22M derived: sum of 3 quarters · filed 2022-02-16 | -$196.62M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$52.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$94.87M derived: sum of 2 quarters · filed 2020-10-29 | -$191.27M 10-Q · filed 2020-10-29 | -$200.98M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | -$41.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$138.39M 10-Q · filed 2020-07-29 | -$148.10M derived: sum of 3 quarters · filed 2021-02-11 | -$182.54M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | -$96.40M 10-Q · filed 2020-04-29 | -$106.11M derived: sum of 2 quarters · filed 2021-02-11 | -$140.56M derived: sum of 3 quarters · filed 2021-02-11 | -$173.20M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | -$9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$44.16M derived: sum of 2 quarters · filed 2021-02-11 | -$76.81M derived: sum of 3 quarters · filed 2021-02-11 | -$139.31M 10-K · filed 2021-02-11 |
| 2018-09-30 | -$34.44M 10-Q · filed 2018-10-23 | -$67.09M derived: sum of 2 quarters · filed 2019-07-25 | -$129.60M 10-Q · filed 2019-10-23 | -$139.39M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | -$32.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$95.15M 10-Q · filed 2019-07-25 | -$104.94M derived: sum of 3 quarters · filed 2020-02-13 | -$141.22M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$62.51M 10-Q · filed 2019-04-25 | -$72.29M derived: sum of 2 quarters · filed 2020-02-13 | -$108.57M derived: sum of 3 quarters · filed 2020-02-13 | -$151.57M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$9.79M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$46.06M derived: sum of 2 quarters · filed 2020-02-13 | -$89.06M derived: sum of 3 quarters · filed 2020-02-13 | -$157.94M 10-K · filed 2020-02-13 |
| 2017-09-30 | -$36.28M 10-Q · filed 2018-10-23 | -$79.28M derived: sum of 2 quarters · filed 2018-10-23 | -$148.16M 10-Q · filed 2018-10-23 | -$169.30M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | -$43.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$111.88M 10-Q · filed 2018-07-26 | -$133.02M derived: sum of 3 quarters · filed 2019-02-15 | -$195.71M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | -$68.88M 10-Q · filed 2018-04-26 | -$90.02M derived: sum of 2 quarters · filed 2019-02-15 | -$152.71M derived: sum of 3 quarters · filed 2019-02-15 | |
| 2016-12-31 | -$21.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$83.83M derived: sum of 2 quarters · filed 2019-02-15 | -$208.44M 10-K · filed 2019-02-15 | |
| 2016-09-30 | -$62.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$187.30M 10-Q · filed 2017-10-26 | ||
| 2016-06-30 | -$124.62M 10-Q · filed 2017-07-27 | |||
| 2015-12-31 | -$227.16M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |